Table 3.
Univariate and Multivariate Cox Regression Analyses of Clinical Characteristics Associated with Progress Free Interval
| Characteristics | Total (N) | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|---|
| Hazard Ratio (95% CI) | P value | Hazard Ratio (95% CI) | P value | ||
| Age | 499 | ||||
| ≤60 | 224 | Reference | |||
| >60 | 275 | 1.302 (0.863–1.963) | 0.208 | ||
| Residual tumor | 468 | ||||
| R0 | 315 | Reference | |||
| R1&R2 | 153 | 2.365 (1.566–3.570) | <0.001 | 1.479 (0.894–2.445) | 0.127 |
| Gleason score | 499 | ||||
| 6and7 | 293 | Reference | |||
| 8and9and10 | 206 | 4.675 (2.957–7.391) | <0.001 | 2.625 (1.472–4.678) | 0.001 |
| T stage | 492 | ||||
| T2 | 189 | Reference | |||
| T3&T4 | 303 | 3.785 (2.140–6.693) | <0.001 | 1.500 (0.759–2.965) | 0.244 |
| Primary therapy outcome | 438 | ||||
| PD&SD | 57 | Reference | |||
| PR&CR | 381 | 0.266 (0.172–0.412) | <0.001 | 0.610 (0.363–1.025) | 0.062 |
| MYBL2 | 499 | 1.620 (1.373–1.912) | <0.001 | 1.250 (1.016–1.537) | 0.035 |
| PSA (ng/mL) | 442 | ||||
| <4 | 415 | Reference | |||
| ≥4 | 27 | 4.196 (2.095–8.405) | <0.001 | 1.913 (0.863–4.245) | 0.110 |
Note: Bold values indicate P<0.05.
Abbreviation: CI, confidence interval.